Embedded Files
Mucosomes: A revolutionary bioinspired platform
Our mission is to harness the power of nature’s defense mechanisms to develop a revolutionary drug delivery platform built on glycosylated mucin nanoparticles. This advanced, scalable, and sustainable technology redefines pharmaceutical development by unlocking API repurposing and maximizing targeting and mucoadhesivity, delivering unmatched results in therapeutic solutions.
Our vision is to be the strategic partner of choice for the pharmaceutical market, offering versatile, high-impact solutions in infectious diseases, oncology, and other mucosal health applications. Committed to relentless innovation, we empower our partners to deliver breakthrough therapies that transform healthcare and improve patient outcomes.
Defined by Breakthrough Features
Our platform integrates synthesis, drug encapsulation, and functionalization into a single-step process, optimizing targeting and mucoadhesivity for enhanced therapeutic performance. Capable of encapsulating a wide range of bioactive compounds, from small molecules to proteins, mucosomes achieve high entrapment efficiency. The technology is engineered for sustainability, utilizing mucin derived from food industry by-products, minimizing solvent use, reducing waste, and offering a scalable, cost-effective solution for pharmaceutical innovation.
Google Sites
Report abuse